Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 201–250 of 256 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07021677	Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"(DARA_T_ALL)	recruiting	Phase 2	18	Tata Memorial CentreOTHER	1	Jun 15, 2025	clinicaltrials
NCT07012447	Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations	recruiting	Phase 2	32	yuejun LiuOTHER	1	Jun 10, 2025	clinicaltrials